Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
19.09. | LEE'S PHARM (00950): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF INTERIM REPORT | 1 | HKEx | ||
19.09. | LEE'S PHARM (00950): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF INTERIM REPORT | 1 | HKEx | ||
19.09. | LEE'S PHARM (00950): INTERM REPORT 2024 | - | HKEx | ||
12.09. | Dividendenbekanntmachungen (12.09.2024) | 8.184 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 3M COMPANY US88579Y1010 0,7 USD EUR AIR NEW ZEALAND LIMITED NZAIRE0001S2 0,015 NZD 0,0083 EUR ALAMOS GOLD INC CA0115321089 0... ► Artikel lesen | |
28.08. | LEE'S PHARM (00950): INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2024 | - | HKEx | ||
28.08. | LEE'S PHARM (00950): INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024 | 1 | HKEx | ||
16.08. | LEE'S PHARM (00950): NOTICE OF BOARD MEETING | 1 | HKEx | ||
01.08. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - THE FIRST PATIENT IN HONG KONG RECEIVES AU409, A NOVEL DRUG PRODUCT MANUFACTURED BY ZHAOKE GUANGZHOU, IN ... | - | HKEx | ||
02.07. | LEE'S PHARM (00950): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
02.07. | LEE'S PHARM (00950): APPOINTMENT OF NON-EXECUTIVE DIRECTOR | 1 | HKEx | ||
20.06. | LEE'S PHARM (00950): GRANT OF SHARE OPTIONS | 1 | HKEx | ||
22.05. | LEE'S PHARM (00950): ANNUAL GENERAL MEETING HELD ON 22 MAY 2024 - POLL RESULTS | 1 | HKEx | ||
19.04. | LEE'S PHARM (00950): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM | 1 | HKEx | ||
19.04. | LEE'S PHARM (00950): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM | 1 | HKEx | ||
19.04. | LEE'S PHARM (00950): PROXY FORM | 2 | HKEx | ||
19.04. | LEE'S PHARM (00950): NOTICE OF ANNUAL GENERAL MEETING | 1 | HKEx | ||
19.04. | LEE'S PHARM (00950): GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES, RE-ELECTION OF DIRECTORS, AND NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
19.04. | LEE'S PHARM (00950): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023 | 1 | HKEx | ||
19.04. | LEE'S PHARM (00950): ANNUAL REPORT 2023 | - | HKEx |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
GILEAD SCIENCES | 77,58 | -0,15 % | Gilead Sciences Stock: HIV Drug Success Boosts Market Position | ||
ZOETIS | 173,44 | -0,24 % | In-Depth Examination Of 7 Analyst Recommendations For Zoetis | ||
SINOPHARM | 2,400 | -2,32 % | Deutliches Plus erfreut Inhaber der Sinopharm Group-Aktie (2,367 €) | Grund zur Freude haben Anleger, die in die Aktie der Sinopharm Group investiert haben: Das Papier verteuert sich am Freitag deutlich. Jahreschart der Sinopharm Group Ltd.-Aktie, Stand 27.09.2024 Ein... ► Artikel lesen | |
CSPC PHARMA | 0,805 | -2,85 % | AstraZeneca Signs Licence Agreement To Develop CSPC Pharma's Lipid Lowering Pre-clinical Asset | LONDON (dpa-AFX) - AstraZeneca PLC (AZN.L) Monday said it has entered into an exclusive license agreement with CSPC Pharmaceutical Group Ltd (CSPC) to develop CSPC's pre-clinical candidate YS2302018... ► Artikel lesen | |
WUXI BIOLOGICS | 2,011 | -6,94 % | Aktienmarkt: Starke Nachfrage treibt Kurs der Wuxi Biologics Cayman-Aktie (2,612 €) | Die Aktie von Wuxi Biologics Cayman zählt am Montag zu den großen Gewinnern am Aktienmarkt. Das Papier steigt deutlich. Ein Wertanstieg auf zwischenzeitlich 2,61 Euro beschert der Wuxi Biologics Cayman-Aktie... ► Artikel lesen | |
SHANGHAI FOSUN PHARMACEUTICAL | 1,770 | -1,94 % | FOSUN PHARMA (02196): ARTICLES OF ASSOCIATION | ||
DR REDDYS | 70,50 | +0,71 % | Dr. Reddy's Laboratories Limited (RDY): Among the Best Indian Stocks for the Next 10 Years | ||
GEDEON RICHTER | 27,160 | -1,31 % | China's Bio-Thera Bags USD110 Million Drug Licensing Deal With Hungary's Gedeon Richter | ||
MEDIPHARM LABS | 0,046 | -1,71 % | MediPharm Labs Corp.: MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA as Gross Profit Continues to Improve | TORONTO, Aug. 14, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based... ► Artikel lesen | |
ASPEN PHARMACARE | 10,100 | 0,00 % | ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in Securities by Directors, Prescribed Officers and the Company Secretary | ||
SHANGHAI PHARMACEUTICALS | 1,440 | -1,37 % | Dividendenbekanntmachungen (17.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMPHENOL CORPORATION US0320951017 0,165 USD 0,1482 EUR ATOUR LIFESTYLE HOLDINGS LTD ADR US04965M1062 0,45 USD 0,4042 EUR BASE RESOURCES... ► Artikel lesen | |
LUYE PHARMA | 0,364 | -3,70 % | Luye Pharma shares see 67% upside potential, Citi lifts target after profitability improvements | ||
SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,079 | -4,27 % | SIHUAN PHARM Leapfrogs 42% Once after Planning Buyback of $500M Max. Shrs | ||
CHINA SHINEWAY PHARMACEUTICAL GROUP | 1,150 | 0,00 % | Dividendenbekanntmachungen (29.04.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 361 DEGREES INTERNATIONAL LTD KYG884931042 0,139 HKD 0,0166 EUR ACROW LIMITED AU0000006124 0,0285 AUD 0,0174 EUR AGNC INVESTMENT... ► Artikel lesen | |
HANSOH PHARMACEUTICAL | 2,520 | -0,79 % | Hansoh Pharmaceutical-Aktie: Kurs legt zu (2,50 €) | Am Aktienmarkt notiert der Anteilsschein von Hansoh Pharmaceutical zur Stunde etwas fester. Zuletzt zahlten Investoren für das Papier 2,50 Euro. Jahreschart der Hansoh Pharmaceutical-Aktie, Stand 04.10.2024... ► Artikel lesen |